NCT04268264View on ClinicalTrials.gov

A Feasibility Study to Test the Acceptability, Tolerance and Safety of Incremental Haemodialysis

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Renal FailureHemodialysis ComplicationMorality
Interventions
PROCEDURE

Incremental haemodialysis

twice weekly haemodilysis at the start, gradually building up to full dose dialysis over a period of 15 weeks

PROCEDURE

Conventional haemodialysis

three times weekly 4-hour long haemodialysis sessions from the start

Trial Locations (1)

HU3 2JZ

Hull University Teaching Hospitals NHS Trust, Hull

All Listed Sponsors
lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT04268264 - A Feasibility Study to Test the Acceptability, Tolerance and Safety of Incremental Haemodialysis | Biotech Hunter | Biotech Hunter